REPLIGEN CORPORATION - COMMON STOCK

Repligen Corporation to Present at 42nd Annual J.P. Morgan Healthcare Conference

19 дек 2023 07:30:00 Источник Nasdaq GlobeNewswire

Repligen Announces Private Convertible Transaction of $600 Million Principal Amount of 1.00% Convertible Senior Notes Due 2028 Through Exchange and New Subscription Agreements

07 дек 2023 07:30:00 Источник Nasdaq GlobeNewswire

UPDATE – Repligen Announces Publication of the Company’s 2022 Sustainability Report

14 ноя 2023 14:01:50 Источник Nasdaq GlobeNewswire

Repligen Announces Publication of the Company’s 2022 Sustainability Report

14 ноя 2023 07:30:00 Источник Nasdaq GlobeNewswire

Repligen Corporation to Present at Upcoming Investor Conferences

07 ноя 2023 07:30:00 Источник Nasdaq GlobeNewswire

Repligen Launches TangenX® SC as First-to-Market Holder-Free Self-Contained TFF Device

02 ноя 2023 07:30:00 Источник Nasdaq GlobeNewswire

Repligen Reports Third Quarter 2023 Financial Results and Updates Full Year 2023 Financial Guidance

31 окт 2023 07:30:01 Источник Nasdaq GlobeNewswire

Repligen to Report Third Quarter 2023 Financial Results

17 окт 2023 07:30:00 Источник Nasdaq GlobeNewswire

Repligen Appoints Olivier Loeillot as President and Chief Commercial Officer

02 окт 2023 07:30:00 Источник Nasdaq GlobeNewswire

Repligen Announces Agreement to Acquire Fluid Management Innovator Metenova

26 сен 2023 07:30:00 Источник Nasdaq GlobeNewswire

Repligen Appoints Jason K. Garland as Chief Financial Officer

12 сен 2023 07:30:00 Источник Nasdaq GlobeNewswire

Repligen Corporation to Present at Wells Fargo Healthcare Conference

01 сен 2023 07:30:00 Источник Nasdaq GlobeNewswire

Sartorius and Repligen Corporation Launch Integrated System with Biostat STR® and XCell® ATF for Upstream Process Intensification

17 авг 2023 08:00:00 Источник Nasdaq GlobeNewswire

Repligen Reports Second Quarter 2023 Financial Results and Updates Full Year 2023 Financial Guidance

02 авг 2023 07:30:01 Источник Nasdaq GlobeNewswire

Repligen to Report Second Quarter 2023 Financial Results

19 июл 2023 07:30:00 Источник Nasdaq GlobeNewswire

Repligen Corporation to Present at Upcoming Investor Conferences

31 май 2023 07:30:00 Источник Nasdaq GlobeNewswire

Repligen Reports First Quarter 2023 Financial Results and Updates Full Year 2023 Financial Guidance

02 май 2023 07:30:00 Источник Nasdaq GlobeNewswire

Repligen to Report First Quarter 2023 Financial Results

18 апр 2023 07:30:00 Источник Nasdaq GlobeNewswire

Repligen Corporation to Present at KeyBanc Life Science and MedTech Investor Forum

14 мар 2023 07:30:00 Источник Nasdaq GlobeNewswire

Repligen Reports Fourth Quarter and Full Year 2022 Financial Results

22 фев 2023 07:30:01 Источник Nasdaq GlobeNewswire